One approach targets the transmembrane glycoprotein mucin1 (MUC-1), which is overexpressed on cancer cells and promotes cancer cell immigration and invasion by activating the transforming growth factor beta (TGF-β)-related signaling pathway [59]. Here, TGFB1 is linked to cancer.